https://www.investors.com/news/technology/mrtx-stock-takes-a-hit-after-receiving-a-lowball-takeover-bid/
0
0
28 words
0
Comments
Bristol Myers Squibb hopes to buy Mirati Therapeutics for up to $5.8 billion.
You are the first to view
Create an account or login to join the discussion